NEUE
Income statement / Annual
Last year (2024), NeueHealth, Inc.'s total revenue was $936.66 M,
a decrease of 19.31% from the previous year.
In 2024, NeueHealth, Inc.'s net income was -$134.68 M.
See NeueHealth, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$936.66 M |
$1.16 B |
$751.16 M |
$1.51 B |
$514.89 M |
$280.67 M |
$130.63 M |
| Cost of Revenue |
$742.14 M
|
$996.58 M
|
$662.97 M
|
$1.29 B
|
$451.92 M
|
$0.00
|
$0.00
|
| Gross Profit |
$194.52 M
|
$164.22 M
|
$88.19 M
|
$218.88 M
|
$62.97 M
|
$280.67 M
|
$130.63 M
|
| Gross Profit Ratio |
0.21
|
0.14
|
0.12
|
0.14
|
0.12
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$19.43 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$273.90 M
|
$259.16 M
|
$315.11 M
|
$388.55 M
|
$168.97 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$76.92 M
|
$34.56 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$273.90 M
|
$259.16 M
|
$315.11 M
|
$465.48 M
|
$221.26 M
|
$180.49 M
|
$95.84 M
|
| Other Expenses |
$28.03 M
|
$482.06 M
|
$70.05 M
|
$97.03 M
|
-$7.34 M
|
$534.00 K
|
-$96.87 M
|
| Operating Expenses |
$301.93 M
|
$741.22 M
|
$385.16 M
|
$562.50 M
|
$233.35 M
|
$181.02 M
|
$96.87 M
|
| Cost And Expenses |
$1.04 B
|
$1.74 B
|
$1.05 B
|
$1.86 B
|
$685.27 M
|
-$405.41 M
|
-$193.27 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$18.70 M
|
$38.20 M
|
$12.82 M
|
$7.23 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$15.65 M
|
$24.17 M
|
$50.58 M
|
$35.05 M
|
$0.00
|
$1.13 M
|
$1.03 M
|
| EBITDA |
-$65.11 M |
-$566.80 M |
-$318.18 M |
-$308.58 M |
-$257.60 M |
-$124.20 M |
-$61.61 M |
| EBITDA Ratio |
-0.07
|
-0.49
|
-0.42
|
-0.2
|
-0.5
|
-0.44
|
-0.47
|
| Operating Income Ratio |
-0.11
|
-0.5
|
-0.49
|
-0.23
|
-0.33
|
-0.45
|
-0.48
|
| Total Other Income/Expenses Net |
$7.95 M
|
-$52.17 M
|
-$12.82 M
|
-$6.00 M
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$99.46 M
|
-$629.17 M
|
-$381.58 M
|
-$349.63 M
|
-$170.38 M
|
-$125.34 M
|
-$62.64 M
|
| Income Before Tax Ratio |
-0.11
|
-0.54
|
-0.51
|
-0.23
|
-0.33
|
-0.45
|
-0.48
|
| Income Tax Expense |
$2.60 M
|
-$1.43 M
|
$3.66 M
|
-$26.52 M
|
-$9.16 M
|
$0.00
|
$0.00
|
| Net Income |
-$134.68 M
|
-$1.15 B
|
-$1.46 B
|
-$1.18 B
|
-$248.44 M
|
-$125.34 M
|
-$62.64 M
|
| Net Income Ratio |
-0.14
|
-0.99
|
-1.94
|
-0.78
|
-0.48
|
-0.45
|
-0.48
|
| EPS |
-22.65 |
-150.94 |
-190.04 |
-150.77 |
-143.42 |
-16.03 |
-8.01 |
| EPS Diluted |
-22.65 |
-150.94 |
-190.04 |
-150.77 |
-143.42 |
-16.03 |
-8.01 |
| Weighted Average Shares Out |
$8.23 M
|
$7.95 M
|
$7.87 M
|
$7.86 M
|
$1.73 M
|
$7.82 M
|
$7.82 M
|
| Weighted Average Shares Out Diluted |
$8.23 M
|
$7.95 M
|
$7.87 M
|
$7.86 M
|
$1.73 M
|
$7.82 M
|
$7.82 M
|
| Link |
|
|
|
|
|
|
|
